Search results
SARS-CoV-2 vaccine does not increase new-onset seizure risk
Medical Xpress· 4 days agoThere is no risk for new-onset seizure incidence for individuals receiving a severe acute...
Man behind China’s first approved Covid-19 shot loses seat in legislature
South China Morning Post· 6 days agoThe NPC statement, which followed a four-day meeting of its standing committee, suggests Yang is...
University of Minnesota strengthens case to treat COVID-19 with metformin, not ivermectin
Minneapolis-St. Paul Star Tribune· 2 days agoThursday's published findings helped connect the dots and explain why metformin in a U-led clinical ...
Scientists tried to give people COVID — and failed
Nature· 4 days agoResearchers deliberately infect participants with SARS-CoV-2 in ‘challenge’ trials — but high levels of immunity complicate efforts to test vaccines and...
YS Biopharma Receives Additional 180 Day Extension by Nasdaq to Regain Compliance with Minimum Bid...
KSAN - KLST San Angelo· 6 days agoYS Biopharma Co., Ltd. (Nasdaq: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations ...
German ex-soldier admits spying for Russia as trial opens
AFP via Yahoo News· 5 days agoA German former soldier on Monday admitted he had spied for Russia at the start of his trial, saying...
Georgetown woman, 3 others found guilty of PPP fraud
FOX 7 Austin· 4 days agoA Georgetown woman was found guilty of conspiracy to commit bank fraud and conspiracy to commit money laundering.
3 Biotech Stocks with Blockbuster Drug Pipelines: April Edition
InvestorPlace· 4 days agoBiotech stocks offer the opportunity to invest in life-saving treatments and drugs. If you want to...
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock...
Digital Journal· 5 days ago(NYSE Amer:NNVC) (the "Company"), a global leader in broad-spectrum antiviral nanomedicines, reports that the Phase I Clinical Trial of NV-387 is completed successfully and ...
A better COVID treatment for the immunocompromised? Researchers create a non-toxic potential...
Medical Xpress· 5 days agoPeople who are infected with SARS-CoV-2, the virus that causes COVID-19, currently have two options...